NicoBloc plc - Smoking Cessation - A High Growth Recession Resistant Business
St. Paul’s Equities Limited (St. Paul’s Equities) is pleased to announce the launch of an Offer for Sale of Shares (NicoBloc or the Company), the latest in a series of pre-Initial Public Offerings (“pre-IPOs”) providing you with the opportunity to invest prior to the Company’s proposed admission to AIM. St. Paul’s Equities is a stockbroker authorised and regulated by the Financial Services Authority (FSA).
Nicobloc
Offer Doc |
Nicobloc
Application |
Nicobloc
Info Sheet |
Nicobloc
Report |
Key Points
NicoBloc has developed a patent protected product, NicoBloc Fluid, to compete in the fast growing smoking cessation market. The Company has already started to make significant gains towards market share in the UK and internationally.
- NicoBloc Fluid has demonstrated its effectiveness and has the potential to secure market share in a market estimated to be worth $2 billion
- The patented product is ready for substantial expansion currently through the world wide distribution networks having already achieved retail sales of £20m over the last 4 years
- Management has appointed G R Lane Healthcare as exclusive UK distributors – which has commercial relationships with Superdrug, Boots Alliance, Lloyds Pharmacy and Holland & Barratt
- Significant success rate of smoking cessation compared to competing products
- The Company is currently developing additional complementary products
- The product is less expensive than most other competing products
- Unique product made from FDA approved food grade ingredients with no reported side effects
- It is NicoBloc’s intention to seek an admission to AIM in due course and as far as we are aware this will be the only such company quoted on AIM
- Market growth is driven by the introduction of anti-smoking legislation internationally (UK, Ireland, France, Scandinavia, Spain, Portugal, USA)
Terms of the Offer and Applying for Shares
The formal terms of this offer are set out in the Offer for Sale of Shares Document and applications for shares are made solely on that basis. Should you wish to read more on this Offer then please contact St. Paul's Equities to request an Offer for Sale of Shares document pack. If you have any questions relating to this Offer and/or the Offer for Sales of Shares Document please contact St. Paul’s Equities on 020 7329 3888 or by email at info@stpaulsequities.com. This Offer is open for a limited time only on a first come, first served basis we therefore recommend prospective investors apply as early as possible after satisfying themselves of the suitability of the investment for their circumstances and attitude to risk.
Risk Warning
Shares in NicoBloc plc are unquoted securities and may be considered to have more risk than quoted securities and shares. The value of investments can go down as well as up. You may have difficulty selling this investment at a reasonable price and, in some circumstances; it may be difficult to sell it at any price. Do not invest in this unless you have carefully thought about whether you can afford it and whether it is right for you and should you have any doubts about the suitability of this investment please consult with a professional adviser in accordance with the Financial Services and Markets Act 2000. The share capital of the Company is not presently listed on any exchange and, whilst it is the belief of the directors of St. Paul’s Equities’ that this is the intention, this cannot be guaranteed. The information contained in this letter does not form part of any offer for sale or subscription to or solicitation to buy or subscribe for any securities or investment product(s). St. Paul’s Equities have sourced your details as a potential investor in Nicobloc plc as we believe you to be a suitable investor on the basis that you are an existing shareholder in such similar stock(s) and/or you have previous experience in medium higher risk, unquoted and private companies and are suitably knowledgeable of the risks associated with such non-readily realisable investments in small cap unquoted or quoted companies. This Document is not a prospectus and contains no offer to the public for purposes of the Prospectus Regulations 2005. St. Paul’s Equities will receive 20% commission on proceeds raised for the company. St. Paul’s Equities Limited (“St. Paul’s Equities”) is authorised and regulated by the Financial Services Authority (“FSA”).
Conclusion
Operating in a recession resistant arena, we believe NicoBloc offers an excellent
opportunity to buy shares in a very promising
company prior to a potential listing. This offer may be withdrawn early if the
issue becomes oversubscribed. We suggest
prospective investors apply as early as
possible.
Terms of the offer and applying for shares
The formal terms of the Offer are contained in the Offer for Sale of Shares Document and applications for shares are made solely on that basis. If you wish to hear and/or see more about this Offer please contact us by telephone on 020 7329 3888, fax 020 7329 3898 or email info@stpaulsequities.com.
Before investing in any unquoted stocks one should note the risks involved. Whilst there is often excellent opportunity to benefit by investing in companies at an early stage of their development and/or prior to a listing, there can be risks involved. Read more here.
To
request further information on any St. Paul's
Equities Offer contact us via e-mail here.
If you wish to become a client then you
will be reuiqred to read and sign the Terms
& Conditions. Call us on 020-7329-3888
for more details.
Or
call 020 7329 3888 for more info
|
